2009 H1N1 pandemic flu more damaging to lungs, opens opportunities for bacterial infection

September 19, 2011

Many of the people who died from the new strain of H1N1 influenza that broke out in 2009 were suffering from another infection as well: pneumonia. A new study to be published Tuesday, September 20 in the online journal mBio reveals how the two infections, pandemic influenza and pneumonia, interact to make to make a lethal combination.

Back in 2009, autopsies of 34 of the victims of the H1N1 pandemic revealed that about half showed signs of bacterial co-infection in their lungs. This was a telling sign that the two pathogens are playing off one another, but until now little was known about the between them or why influenza was so lethal when accompanied by pneumonia.

Using mice, Kash et al., from the National Institute of Allergy and Infectious Diseases (NIAID) and the Institute for Systems Biology (ISB), teased the problem apart. They infected some mice with the seasonal flu virus and others with the 2009 pandemic strain and waited 48 hours for the influenza to take hold. Next, they exposed some of the mice to the bacterium , one of the leading causes of pneumonia.

In mice that were only given either of the , influenza had the same effects it has in humans, including weight loss, but all the mice infected with influenza alone survived. The mice infected with seasonal influenza and S. pneumoniae had slightly enhanced damage, but they all survived the dual infections.

In contrast, all the mice co-infected with both the 2009 pandemic flu and S. pneumoniae showed severe weight loss and 100% mortality. The lung tissues of the dead mice revealed that the were severely inflamed and the surfaces of the bronchioles were wiped clean of the protective layer of cells called the epithelium. There was also increased bacterial replication in the lungs of the co-infected mice, a sign that the bacteria were thriving there.

Looking at the mouse genes that were expressed during infection revealed more details about how the virus sets the stage for lethal bacterial infections. Mice infected with the pandemic and S. pneumoniae had a similar inflammatory response as the other mice, but they lack responses that would repair and regenerate their damaged epithelial cells, those protective tissues that would otherwise keep bacteria from penetrating to deeper layers of tissue.

All these factors add up to big problems in the lung: as compared with seasonal flu, infection with the pandemic strain of flu was associated with more extensive damage to the that requires more extensive tissue repair. This opens the body up to attack from bacterial invaders, including Streptococcus pneumoniae.

Keith Klugman, who studies pneumonia and pneumococcal disease at Emory University, edited the paper. He says the study has a number of implications for treatment of pandemic flu.

"One implication is that if you can prevent the bacterial infection, you may be able to prevent a significant fraction of the pneumonia that leads to death. There may be a role for antibiotics in the severe pneumonias that follow influenza," says Klugman.

Klugman points out that a vaccine for S. pneumoniae exists and that it is effective at interrupting transmission of pneumonia in the community. Now that we know causes increased susceptibility to pneumonia, says Klugman, we might head off deadly influenza-S. pneumoniae co-infections with more proactive vaccination programs.

Related Stories

Recommended for you

The 'love hormone' may quiet tinnitus

September 23, 2016

(HealthDay)—People suffering from chronic ringing in the ears—called tinnitus—may find some relief by spraying the hormone oxytocin in their nose, a small initial study by Brazilian researchers suggests.

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.